On June 18, 2025, Dogwood Therapeutics, Inc. held an annual meeting where shareholders approved an increase of 108,612 shares in its equity incentive plan, raising the total shares to 191,112. This event is significant as it reflects shareholder support and management's strategy for incentivizing employees.